Literature DB >> 27926764

Prevention of Heart Failure.

Tamara B Horwich, Gregg C Fonarow.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27926764     DOI: 10.1001/jamacardio.2016.3394

Source DB:  PubMed          Journal:  JAMA Cardiol            Impact factor:   14.676


× No keyword cloud information.
  4 in total

1.  Secular Trends in Prevalence of Heart Failure Diagnosis over 20 Years (from the US NHANES).

Authors:  George Cm Siontis; Deepak L Bhatt; Chirag J Patel
Journal:  Am J Cardiol       Date:  2022-03-28       Impact factor: 3.133

2.  Sacubitril-Valsartan Compared With Enalapril for the Treatment of Heart Failure: A Decision-Analytic Markov Model Simulation in China.

Authors:  Yue Wu; Shuo Tian; Peipei Rong; Fan Zhang; Ying Chen; Xianxi Guo; Benhong Zhou
Journal:  Front Pharmacol       Date:  2020-07-23       Impact factor: 5.810

Review 3.  Glycemic control and atrial fibrillation: an intricate relationship, yet under investigation.

Authors:  Andreas S Papazoglou; Anastasios Kartas; Dimitrios V Moysidis; Christos Tsagkaris; Stavros P Papadakos; Alexandra Bekiaridou; Athanasios Samaras; Efstratios Karagiannidis; Marios Papadakis; George Giannakoulas
Journal:  Cardiovasc Diabetol       Date:  2022-03-14       Impact factor: 9.951

4.  Contemporary use of SGLT2 inhibitors in heart failure patients with diabetes mellitus: a comparison of DPP4 inhibitors in a nationwide electric health database of the superaged society.

Authors:  Michikazu Nakai; Yoshitaka Iwanaga; Koshiro Kanaoka; Yoko Sumita; Yuichi Nishioka; Tomoya Myojin; Shinichiro Kubo; Katsuki Okada; Tsunenari Soeda; Tatsuya Noda; Yasushi Sakata; Tomoaki Imamura; Yoshihiko Saito; Satoshi Yasuda; Yoshihiro Miyamoto
Journal:  Cardiovasc Diabetol       Date:  2022-08-13       Impact factor: 8.949

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.